Carisoprodol

Overview

Carisoprodol is a centrally acting skeletal muscle relaxant used for the relief of discomfort associated with musculoskeletal conditions. It is typically used short-term and often in combination with rest, physical therapy, and other measures.

API suppliers (15)

Suppliers of Carisoprodol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• SIEGFRIED EVIONNAZ SASwitzerland1 active DMF GMP on record
• UQUIFA ITALIA SPAItaly1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• HARMAN FINOCHEM LTDIndia1 active DMF GMP on record
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
• OLON SPAItaly1 active DMF GMP on record
• CHEMECA DRUGS PRIVATE LTDIndia1 active DMF
• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD GMP on record
• UQUIFA MEXICO SA DE CV
• FLEMING LABORATORIES LTDIndia GMP on record
• Sun Pharmaceutical Industries LimitedIndia GMP on record
• POLYDRUG LABORATORIES PVT LTD
• Isochem SasFrance
• Zhejiang Charioteer Pharmaceutical Co., Ltd.China GMP on record
• WARD BLENKINSOP AND CO LTD

Chemical identity

IUPAC name

[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate

Canonical SMILES

CCCC(C)(COC(=O)N)COC(=O)NC(C)C

InChIKey

OFZCIYFFPZCNJE-UHFFFAOYSA-N

Therapeutic areas